Skip to main content
IMS Events Main banner
Back

    P.Joy Ho, MBBS DPhil FRACP FRCPA

    Director
    Institute of Haematology, Royal Prince Alfred Hospital
    Camperdown, New South Wales, Australia

    Prof. Joy Ho is Professor, Alan Ng Chair in Haematology, University of Sydney, and Head of Department & Director of Research at the Institute of Haematology, Royal Prince Alfred Hospital (RPAH), Sydney. She is Clinical Lead, Haematology CAR-T Program and Head of the Myeloma Unit in RPAH. She is Founding Director of Sydney Blood Cancer Research Institute. She is co-chair of the Myeloma Working Group of the Australasian Leukemia and Lymphoma Group (ALLG), Foundation Member and was Deputy Chair of the Medical and Scientific Advisory group of Myeloma Australia, and a member of the International Myeloma Working Group (IMWG) since its inception. She was elected to the Board of the International Myeloma Society in 2019, and has served on the Education Committee since 2016. For the American Society of Hematology (ASH), she is the current Chair of the International Members’ Committee. She was President of the Haematology Society of Australia and New Zealand (HSANZ) in 2013-15. In 2017-2021, she was appointed to the Pharmaceutical Benefits Advisory Committee by the Australian Government. Her research achievements include stewardship of national clinical trials, and has brought multiple clinical trials on novel CAR-T, myeloma and lymphoma therapies to RPAH and Australia. She served on the ALLG Scientific and Executive Committees, and chaired the Laboratory Science Committee. Awards received include the Carl de Gruchy Oratorship (HSANZ) in 2022, Inaugural HSANZ Leadership Award in 2023, Albert Baikie Memorial Medal, Kanematsu Memorial Award, and Oxford Nuffield Medical Fellowship. She is author of multiple publications on myeloma, lymphoma, cellular immunotherapy and haemoglobinopathies.

    Disclosure information not submitted.

    Presentation(s):